<unk>  is an antineoplastic that is FDA approved for the treatment of colorectal cancer, gastrointestinal stromal tumors. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include hypertension, mucositis, dysphonia, infection, pain.
Regorafenib
Encorafenib
Brigatinib
Fostamatinib
Neratinib
Dasatinib
Afatinib
Vemurafenib